Jarrod Sandow

@jsandow.bsky.social

Chief Product Officer at IonOpticks | Separator of peptides and proteoforms | Proteomics

New PCA-N workflow enables 10,000+ plasma samples/day using just 5µL per sample. Doubles protein coverage vs standard methods. Uses Evosep One LC with Orbitrap Astral MS, Aurora Rapid 8x150 column & EASY-Spray Source. Validated across 34,500 samples over 311 days. Learn more: bit.ly/3RQd3o2

Bild

I'm excited to announce that we're expanding our leadership team at IonOpticks. We're searching for an exceptional Product Director with deep scientific expertise in chromatography and LC-MS to lead our Product Development team during an exciting phase of global growth. Apply here: bit.ly/43VoC4t

Product Director - LC-MS - SEEK

Exciting leadership opportunity to join an Aust-based tech company on a global mission to revolutionise the field of chromatography & proteomics.

bit.ly

“Habit becomes the enemy of innovation. And there’s a lot of space to innovate.” Dr. Samantha Emery-Corbin, research fellow at the Monash Proteomics and Metabolomics Platform, discusses the art of scientific storytelling and potentially transformative sepsis treatment research. bit.ly/41EGEXa

From Parasites to Proteomics: how Dr. Samantha Emery-Corbin is Bridging Biology and Big Data - IonOpticks

Interview with Dr Samantha Emery-Corbin, a research fellow at the Monash Proteomics and Metabolomics Platform in Melbourne.

bit.ly

Breakthrough in FFPE Tissue Proteomics: Haines et al. develop new workflow for deep proteomic analysis of archived tissue samples. Aurora Elite XT coupled with Orbitrap Astral to achieve precise peptide separation. Read the full study: bit.ly/4gUVkqw

Bild

A new manuscript from Karl Mechtler’s team investigates the optimal crosslinking mass spectrometry (CL-MS) workflow. As it turns out, the Orbitrap Astral + Aurora Ultimate is a powerful combination that opens up a completely new dimension for CL-MS. Read the full manuscript over at bit.ly/41OlE0J

Bild

It’s exciting to see more and more studies coming in that use our recently launched Aurora Rapid 8x150 columns. In a new highlight, Heaton et al. investigate the role of LRRK2 mutations in Crohn's disease (CD) and Parkinson's disease (PD). Learn more: bit.ly/3Z36Zfc #LRRK2 #CrohnsDisease

Preprint: Targeting Specific Kinase Substrates Rescues Increased Colitis Severity Induced by the Crohn’s Disease-Linked LRRK2-N2081D Variant - IonOpticks

This colitis severity study by Heaton et al. was conducted utilising an 8cm IonOpticks Aurora Rapid UHPLC column.

bit.ly